Dr. Roland Griffiths, Heffter board member, at the Johns Hopkins University School of Medicine is the subject of two articles on the long lasting positive affects of psilocybin on personality. Dr. Griffiths study was also published in The Journal of Psychopharmacology. He is, currently, leading two studies on anxiety reduction in cancer patients and smoking cessation therapy with the use of psilocybin. These studies are supported in part by the Heffter Research Institute . The
The PSILOCYBIN CANCER ANXIETY STUDY at NYU under the direction of Heffter board member Dr. Stephen Ross has launched their new web site. They are looking for volunteers to participate in a scientific study exploring the effects of spiritual or mystical states of consciousness on anxiety and emotional distress associated with a diagnosis of advanced, recurrent, or potentially life threatening cancer.
The study was conducted by Dr. Roland Griffiths and his co-researchers at the Johns Hopkins University School of Medicine. Please read and ponder the implications of this fascinating study and its conclusions at the following link. https://www.springerlink.com/content/u464377x433p5957/fulltext.pdf Dr. Griffiths is currently engaged in a Psilocybin study designed toÂ ameliorateÂ the symptoms of anxiety and depression in those facing a diagnosis of lifeÂ threatening cancer. The study is open and actively recruiting patients.
Psilocybin research conducted by Dr. Roland Griffiths at the Johns Hopkins University School of Medicine has been featured in TIME magazine. Please follow the link. https://healthland.time.com/2011/06/16/magic-mushrooms-can-improve-psychological-health-long-term/#more-36198
The continuing study at Johns Hopkins University School of Medicine on psilocybin and its potential in the treatment of anxiety and depression in those facing lifeÂ threatening cancer is the topic in the journal Â Psychopharmacology . Please follow the links to the Â press release and the Yahoo news story for more information. www.csp.org/psilocybin/PressRelease201106.pdf Also take note of an observation made by “Jerome Jaffe, M.D., of the University of Maryland School ofÂ Medicine, who served as the
TheÂ completeÂ 2011Â presentations of speakers at MANIFESTING THE MIND in Madison Wisconsin are now available on-line. Please follow the link and enjoy an incredible array of speakersÂ discussingconsciousnessÂ and the neurology involved in the process.
Heffter scientists will be speaking at this conference, in Madison, WI on April 28-29, 2011: OVERVIEW: The over-arching theme of this Forum’s is exploration of the Mind-Brain phenomenon and how this relates to human consciousness. The challenge faced by planners of Manifesting the Mind was to respect the many interests of our audience, to cover a wide range of topics — ethnobotany to neurotransmitters to recent clinical reports on the use of entheogens. One goal
The Archives of General Psychiatry has just published the report of Dr. Charles Grob’s experimental treatment of anxiety in cancer patients. You can view the abstract here: Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2011) Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer. Arch Gen Psychiatry. 2011 Jan;68(1):71-8. The online publication in September, 2010 generated quite a bit of media attention, and here are
Screening will be in Namaste Hall, 1453 Mission Street, 3rd floor, San Francisco, CA. Included in the film is an interview with Annie Levy about her experience taking psilocybin as a cancer patient in Dr. Charles Grob’s research study. 7:00 pm Welcome by Joseph Subbiondo 7:15 to 8:30 pm Film screening 8:30 to 9:15 pm Panel discussion with Robert Barnhart, Roslyn Dauber, Frank Echenhofer, and Charles Grob.
On February 24, 2010, Scienceline published this story about Pam Sakuda, the first person in decades to talk about the experience of psychedelic treatment in a research study. Read the Scienceline story here…